Molecular Neurobiology, Год журнала: 2024, Номер unknown
Опубликована: Окт. 26, 2024
Язык: Английский
Molecular Neurobiology, Год журнала: 2024, Номер unknown
Опубликована: Окт. 26, 2024
Язык: Английский
Peptides, Год журнала: 2024, Номер 179, С. 171268 - 171268
Опубликована: Июнь 28, 2024
Язык: Английский
Процитировано
5Neurotherapeutics, Год журнала: 2023, Номер 21(1), С. e00302 - e00302
Опубликована: Дек. 19, 2023
Paclitaxel, a frequently utilized chemotherapeutic agent, often gives rise to severe and distressing sensory neuropathy in patients undergoing chemotherapy. Unfortunately, current therapeutics for chemotherapy-induced neuropathic pain (CINP) demonstrate limited effectiveness are burdened with the potential central side effects such as sedation, respiratory depression, cognitive impairment, addiction, posing substantial clinical challenges. In light of these limitations, present study is designed investigate therapeutic Dermorphin [D-Arg2, Lys4] (1-4) amide (DALDA), preferential peripherally acting mu-opioid receptor agonist, rat model CINP. The primary objective was assess analgesic properties DALDA elucidate underlying mechanisms governing its activity. Our findings revealed that treatment significantly ameliorated paclitaxel-induced evoked spontaneous ongoing rats without causing drug addiction other effects. Molecular analyses further unveiled paclitaxel administration resulted increased expression TRP channels, NR2B, voltage-gated sodium channels (VGSCs) neuroinflammatory markers both dorsal root ganglion (DRG) spinal cord (L4-L5 region) rats. downregulated ion (TRPs, VGSCs) NR2B expressions, concomitant inhibition microglial activation, resulting suppression oxido-nitrosative stress cascade. Findings from suggests peripheral receptors may offer target suffering CINP, offering new avenues improved relief while minimizing
Язык: Английский
Процитировано
11Molecular Neurobiology, Год журнала: 2024, Номер 61(8), С. 6089 - 6100
Опубликована: Янв. 26, 2024
Язык: Английский
Процитировано
3Neurochemistry International, Год журнала: 2024, Номер unknown, С. 105863 - 105863
Опубликована: Сен. 1, 2024
Язык: Английский
Процитировано
2Cellular Signalling, Год журнала: 2024, Номер 115, С. 111028 - 111028
Опубликована: Янв. 2, 2024
Язык: Английский
Процитировано
2International Journal of Pharmaceutics, Год журнала: 2024, Номер 669, С. 125082 - 125082
Опубликована: Дек. 12, 2024
Язык: Английский
Процитировано
1Journal of Pain Research, Год журнала: 2024, Номер Volume 17, С. 1639 - 1650
Опубликована: Май 1, 2024
Background: The mechanism of Chemotherapy-induced neuropathic pain (NP) remains obscure. This study was aimed to uncover the key genes as well protein networks that contribute Oxaliplatin-induced NP. Material/Methods: Oxaliplatin frequently results in a type NP is marked by heightened sensitivity mechanical and cold stimuli, which can lead intolerance discontinuation medication. We investigated whether these different etiologies similar pathological outcomes targeting shared genetic targets or signaling pathways. Gene expression data were obtained from Expression Comprehensive Database (GEO) for GSE38038 (representing differential spinal nerve ligation model rats) GSE126773 among rats). Differential gene analysis performed using GEO2R. Results: Protein-protein interaction (PPI) identified 260 co-differentially expressed (co-DEGs). Subsequently, Kyoto Encyclopedia Genes Genomes (KEGG) revealed three pathways involved both models: Kaposi sarcoma-associated herpesvirus (KSHV) infection, Epstein-Barr virus (EBV) AGE-RAGE pathway diabetic complications. Further bioinformatics highlighted eight significantly up-regulated group: Mapk14, Icam1, Cd44, IL6, Cxcr4, Stat1, Casp3 Fgf2. Our suggest immune dysfunction, inflammation-related factors regulating inflammation may also be related Additionally, we analyzed dataset (GSE145222) involving chronic compression DRGs (CCD) control groups. CCD classic studying assessed hub genes' levels. In contrast with groups, difference statistically significant, except Stat1. Conclusion: research contributes elucidating mechanisms underlying occurrence progression have crucial associated this condition. Keywords: pain, oxaliplatin, dorsal horn, bioinformatics, differentially genes,
Язык: Английский
Процитировано
0Current Opinion in Pharmacology, Год журнала: 2024, Номер 76, С. 102465 - 102465
Опубликована: Июнь 1, 2024
Ligand bias offers a novel means to improve the therapeutic profile of drugs. With regard G protein-coupled receptors involved in analgesia, it could be advantageous develop such drugs if analgesic effect is mediated by different cellular signalling pathway than adverse effects associated with drug. Whilst this has been explored over number years for μ receptor, remains unclear whether approach significant benefit treatment pain. Nevertheless, development biased ligands at other CNS does offer some promise future. Here we summarise and discuss recent evidence support this.
Язык: Английский
Процитировано
0BMC Neuroscience, Год журнала: 2024, Номер 25(1)
Опубликована: Сен. 15, 2024
Язык: Английский
Процитировано
0Molecular Neurobiology, Год журнала: 2024, Номер unknown
Опубликована: Окт. 26, 2024
Язык: Английский
Процитировано
0